HIMCH
GHDX

Hartford Investment Management Co (HIMCO)’s Genomic Health, Inc. GHDX Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,954
Closed -$383K – 724
2018
Q4 		$383K Hold
5,954
– – 0.01% 543
2018
Q3 		$418K Sell
5,954
-397
-6% -$23.2K 0.01% 554
2018
Q2 		$320K Buy
+6,351
New +$252K 0.01% 595

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s GHDX Position: Q1 2019 in Review

Hartford Investment Management Co (HIMCO) sold out of Genomic Health, Inc. (GHDX) in Q1 2019, closing a stake of 5,954 shares — an estimated $383K sold.

Hartford Investment Management Co (HIMCO) first reported a position in GHDX in Q2 2018 and held it in 3 quarters. The position peaked at $418K in Q3 2018. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

  • Hartford Investment Management Co (HIMCO) reported no remaining Genomic Health, Inc. position as of Q1 2019 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 5,954 Genomic Health, Inc. shares in Q1 2019, an estimated $383K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 3 quarters.
  • Hartford Investment Management Co (HIMCO)'s Genomic Health, Inc. position peaked at $418K in Q3 2018.
  • 267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q1 2019, filed 29 Apr 2019.